Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
23.40
-0.28 (-1.18%)
At close: Oct 12, 2026, 4:00 PM EDT
23.37
-0.03 (-0.13%)
Pre-market: Oct 13, 2026, 4:00 AM EDT
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of $1.19 billion as of October 12, 2026. Its market cap has decreased by 5.32% in one year.
Market Cap
1.19B
Enterprise Value
1.18B
1-Year Change
-5.32%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since the IPO on December 11, 2020, Nanobiotix's market cap has increased from $549.07M to $1.19B, an increase of 116.47%. That is a compound annual growth rate of 14.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 1.19B | 7.30% |
| Dec 31, 2025 | 1.11B | 646.33% |
| Dec 31, 2024 | 148.41M | -57.08% |
| Dec 29, 2023 | 345.77M | 156.45% |
| Dec 30, 2022 | 134.83M | -53.41% |
| Dec 31, 2021 | 289.40M | -50.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alpha Tau Medical | 1.32B |
| Damora Therapeutics | 1.25B |
| Replimune Group | 1.23B |
| Savara | 1.23B |
| ORIC Pharmaceuticals | 1.22B |
| First Tracks Biotherapeutics | 1.22B |
| Vor Biopharma | 1.17B |
| LB Pharmaceuticals | 1.16B |